Verifying…
Home / Drug A–Z / Srowk Tablets Prolonged Release Potassium Chloride

Srowk Tablets Prolonged Release Potassium Chloride

NAFDAC Reg. No. A4-101103 · Drug

Registered with NAFDAC — registration activeAs of 6 November 2026 · synced automatically from official sources.
Product
Srowk Tablets Prolonged Release Potassium Chloride
NAFDAC number
A4-101103
Active ingredient
Potassium chloride
Strength
600 mg
Form
Prolonged-release tablet
Pack size
4 x 10's (in Alu-PVC blisters)
Manufacturer
Not listed
Applicant (holder)
Impexxia Pharma Ltd
Approved
22 Nov 2024
Status
Active View on NAFDAC ↗
Registration valid to
21 Nov 2029
WHO alerts
None found
Community reports
None
Times checked
0

RxVerify commentary

  • Srowk Tablets Prolonged Release Potassium Chloride is on the NAFDAC register with an active registration (A4-101103). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. Not medical advice — always follow your doctor or pharmacist.

What Srowk Tablets Prolonged Release Potassium Chloride is used for

From the official U.S. FDA label for potassium chloride, the active ingredient registered with NAFDAC.

What it is used for

For handwashing to decrease bacteria on the skin

Purpose

Antibacterial

Possible side effects

irritation and redness develop condition persists for more than 72 hours

Warnings

For external use only: hands only

General information only — not dosing advice. Always follow the leaflet in your pack and your doctor or pharmacist.

Check your pack of Srowk Tablets Prolonged Release Potassium Chloride

Add the expiry date printed on your pack for a full Trust Score — or look up uses, side effects and cheaper generics.

3 free checks left today · no signup Official sources: NAFDAC Green Book & recalls · WHO · U.S. FDA · NLM RxNorm

About Srowk Tablets Prolonged Release Potassium Chloride

What is in Srowk Tablets Prolonged Release Potassium Chloride?

Srowk Tablets Prolonged Release Potassium Chloride contains Potassium chloride (600 mg), as prolonged-release tablet, according to its NAFDAC registration record.

Is Srowk Tablets Prolonged Release Potassium Chloride registered with NAFDAC?

Yes. Srowk Tablets Prolonged Release Potassium Chloride is listed on the NAFDAC register under registration number A4-101103, and its registration is active as of 6 November 2026.

Has Srowk Tablets Prolonged Release Potassium Chloride been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Srowk Tablets Prolonged Release Potassium Chloride in our automatically synced alert list.

How can I check that my pack of Srowk Tablets Prolonged Release Potassium Chloride is genuine?

Run a free authenticity scan with the NAFDAC number A4-101103, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

What is Srowk Tablets Prolonged Release Potassium Chloride used for?

For handwashing to decrease bacteria on the skin (Summarised from the official U.S. FDA label for potassium chloride. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Srowk Tablets Prolonged Release Potassium Chloride? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from RxVerify users, not medical advice. Report side effects to your doctor and to NAFDAC.